Patents by Inventor Sandra Elizabeth Esparon

Sandra Elizabeth Esparon has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • MODIFIED IMMUNOGLOBULIN WITH AFFINITY FOR FcGAMMARIIb AND METHOD OF USE THEREOF
    Publication number: 20240018269
    Abstract: Immunotherapeutic proteins comprising at least one heavy chain polypeptide derived from an IgG2 antibody are disclosed, wherein the heavy chain polypeptide comprises at least constant heavy domains 2 and 3 (CH2 and CH3) and the lower hinge, and the sequence of the lower hinge comprises a mutation enabling the immunotherapeutic protein to bind to and/or activate Fc?RIIb. The immunotherapeutic protein is suitable for use in methods of treating diseases or conditions wherein, for example, the activation of Fc?RIIb (ie for recruitment of the inhibitory functions of Fc?RIIb) is beneficial, such as allergic diseases.
    Type: Application
    Filed: June 23, 2023
    Publication date: January 18, 2024
    Inventors: Phillip Mark HOGARTH, Bruce David WINES, Halina Mary TRIST, Sandra Elizabeth ESPARON, Alicia Michelle CHENOWETH
  • Flu vaccine admixture of mannan and flu antigen
    Patent number: 8182821
    Abstract: The present invention relates to a vaccine composition comprising a carbohydrate polymer comprising mannose and flu antigen(s) (e.g. whole inactivated influenza virus) in admixture, and a method of immunising a subject comprising the step of administering the vaccine composition to a subject.
    Type: Grant
    Filed: October 2, 2007
    Date of Patent: May 22, 2012
    Assignee: The MacFarlane Burnet Institute for Medical Research and Public Health Ltd.
    Inventors: Geoffrey Allan Pietersz, Sandra Elizabeth Esparon, Owen Proudfoot
  • FLU VACCINE ADMIXTURE OF MANNAN AND FLU ANTIGEN
    Publication number: 20100008951
    Abstract: The present invention relates to a vaccine composition comprising a carbohydrate polymer comprising mannose and flu antigen(s) (e.g. whole inactivated influenza virus) in admixture, and a method of immunising a subject comprising the step of administering the vaccine composition to a subject.
    Type: Application
    Filed: October 2, 2007
    Publication date: January 14, 2010
    Applicant: THE MACFARLANE BURNET INSTITUTE FOR MEDICAL RESEARCH AND PUBLIC HEALTH LIMITED
    Inventors: Geoffrey Allan Pietersz, Sandra Elizabeth Esparon, Owen Proudfoot